• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查中愈创木脂法与免疫粪便潜血试验的比较:患者视角

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.

作者信息

Deutekom Marije, van Rossum Leo G M, van Rijn Anne F, Laheij Robert J F, Fockens Paul, Bossuyt Patrick M M, Dekker Evelien, Jansen Jan B M J

机构信息

Department of Social Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.

DOI:10.3109/00365521.2010.497937
PMID:20560814
Abstract

OBJECTIVE

Colorectal cancer (CRC) screening programs can decide upon the type of fecal occult blood test (FOBT): the guaiac FOBT (g-FOBT) or the immunological FOBT (i-FOBT). The effectiveness of any screening program depends not only on the diagnostic performance of the screening test but also on the compliance and general acceptance of the test by the public. Any decision on the type of FOBT for CRC screening should also take acceptation and perception into account. The aim of the present study was to study differences in patient perception between i-FOBT and g-FOBT and differences in perception and participation rates among relevant subgroups in a population based study.

MATERIAL AND METHODS

Differences in patient perception of i-FOBT and g-FOBT and differences in perception and participation rates among relevant subgroups were investigated (n = 20,623) by sending a short questionnaire to all invited to the first Dutch CRC screening trial.

RESULTS

i-FOBT was perceived significantly more favorable than g-FOBT. About 1275 (32%) participants reported the g-FOBT not easy to use, not easy to perform, disgusting or shameful compared to 742 (16%) for the i-FOBT (p < 0.001). The participation rate was significantly higher in those who received i-FOBT compared to the g-FOBT group: 6159 of 10,322 (60%) versus 4839 of 10,301 (47%) (p < 0.001).

CONCLUSIONS

These findings support the selection of i-FOBT as the more appropriate test for population screening programs.

摘要

目的

结直肠癌(CRC)筛查项目需要决定粪便潜血试验(FOBT)的类型:愈创木脂法粪便潜血试验(g-FOBT)或免疫法粪便潜血试验(i-FOBT)。任何筛查项目的有效性不仅取决于筛查试验的诊断性能,还取决于公众对该试验的依从性和普遍接受度。关于用于CRC筛查的FOBT类型的任何决定也应考虑接受度和认知度。本研究的目的是在一项基于人群的研究中,研究i-FOBT和g-FOBT在患者认知方面的差异,以及相关亚组在认知率和参与率方面的差异。

材料与方法

通过向所有受邀参加首次荷兰CRC筛查试验的人发送一份简短问卷,调查i-FOBT和g-FOBT在患者认知方面的差异,以及相关亚组在认知率和参与率方面的差异(n = 20623)。

结果

i-FOBT的认可度明显高于g-FOBT。约1275名(32%)参与者表示g-FOBT使用不便、操作不易、令人厌恶或感到羞耻,而i-FOBT为742名(16%)(p < 0.001)。与g-FOBT组相比,接受i-FOBT的人的参与率明显更高:10322人中的6159人(60%),而10301人中的4839人(47%)(p < 0.001)。

结论

这些发现支持选择i-FOBT作为人群筛查项目中更合适的检测方法。

相似文献

1
Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.结直肠癌筛查中愈创木脂法与免疫粪便潜血试验的比较:患者视角
Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.
2
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.在筛查人群中对粪便潜血愈创木脂法检测和免疫化学法检测用于结直肠癌筛查的随机对照比较。
Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.
3
Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.2004-2008 年韩国在有组织的结直肠癌筛查项目中对粪便潜血检测阳性后的随访依从性。
J Gastroenterol Hepatol. 2012 Jun;27(6):1070-7. doi: 10.1111/j.1440-1746.2011.06944.x.
4
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].[用于结直肠癌筛查中粪便潜血检测的化学或免疫检测?]
Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3.
5
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.
6
Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.免疫化学粪便潜血试验在检测结直肠肿瘤方面优于基于愈创木脂的试验。
Eur J Cancer. 2008 Oct;44(15):2254-8. doi: 10.1016/j.ejca.2008.06.041. Epub 2008 Aug 27.
7
Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.在一项针对结直肠癌筛查计划中,对粪便隐血试验呈阳性的个体进行免疫化学检测:一项观察性研究。
Lancet Oncol. 2006 Feb;7(2):127-31. doi: 10.1016/S1470-2045(05)70473-3.
8
Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.安大略省的结肠癌筛查项目:加拿大首个全省范围内结直肠癌筛查项目的结果
Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):508-15. doi: 10.1158/1055-9965.EPI-13-0956. Epub 2014 Jan 17.
9
[Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].职业健康检查中结直肠癌的早期检测:从基于愈创木脂的粪便潜血试验转向免疫化学粪便潜血试验
Dtsch Med Wochenschr. 2014 Jan;139(3):79-83. doi: 10.1055/s-0033-1349588. Epub 2013 Oct 2.
10
Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.法国使用愈创木脂测试与免疫化学测试筛查结直肠癌的成本效益比较。
Int J Technol Assess Health Care. 2010 Jan;26(1):40-7. doi: 10.1017/S026646230999078X.

引用本文的文献

1
Implementation Strategies for Interventions Aiming to Increase Participation in Mail-Out Bowel Cancer Screening Programs: A Realist Review.旨在提高邮寄式肠癌筛查项目参与率的干预措施实施策略:一项实效主义综述
Front Oncol. 2020 Sep 29;10:543732. doi: 10.3389/fonc.2020.543732. eCollection 2020.
2
Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis.增加邮件式结直肠癌筛查计划参与率的策略:系统评价和荟萃分析。
Syst Rev. 2019 Nov 4;8(1):257. doi: 10.1186/s13643-019-1170-x.
3
"Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
“找到合适的匹配度”:农村患者对粪便免疫化学检测(FIT)特征的偏好
J Am Board Fam Med. 2017 Sep-Oct;30(5):632-644. doi: 10.3122/jabfm.2017.05.170151.
4
Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer.血小板中凝聚素和谷胱甘肽合成酶的蛋白水平可早期检测结直肠癌。
Cell Mol Life Sci. 2018 Jan;75(2):323-334. doi: 10.1007/s00018-017-2631-9. Epub 2017 Aug 28.
5
New era of colorectal cancer screening.结直肠癌筛查的新时代。
World J Gastrointest Endosc. 2016 Mar 10;8(5):252-8. doi: 10.4253/wjge.v8.i5.252.
6
Colorectal cancer screening: 20 years of development and recent progress.结直肠癌筛查:20年的发展与近期进展
World J Gastroenterol. 2014 Apr 14;20(14):3825-34. doi: 10.3748/wjg.v20.i14.3825.
7
Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.基于人群的结直肠癌筛查的成本效益:愈创木脂粪便隐血试验、粪便免疫化学试验和乙状结肠镜检查的比较。
Br J Cancer. 2012 Feb 28;106(5):805-16. doi: 10.1038/bjc.2011.580. Epub 2012 Feb 16.